Pfizer Canada and BioNTech Initiate Rolling Submission to Health Canada for SARS-CoV-2 Vaccine Candidate BNT162b2
KIRKLAND, QUEBEC, CANADA and MAINZ, GERMANY, October 9, 2020 — Pfizer Canada and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a rolling submission to Health Canada for BNT162b2, the lead candidate from...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Canada Health | Clinical Trials | Germany Health | Pfizer | Pharmaceuticals | SARS | Vaccines